STUDY: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors (Alliance for Clinical Trials in Oncology)
This randomized phase III trial compares standard-dose combination chemotherapy to high-dose combination chemotherapy with stem cell transplant to treat patients with refractory or relapsed germ cell tumours.
- Age Eligibility: 14 years and over
- NOL Date: Canadian NOL June 1, 2016
- Cooperative Group: Alliance for Clinical Trials in Oncology, sponsored in Canada by C17 for pediatric centres
- NCT02375204, Alliance Protocol A031102